1 asset in Hyperlipoproteinemia

Therapeutic assets addressing Hyperlipoproteinemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Isis-681257 (Galnac3--Conjugated Aso Targeting Human Lipoprotein (A) ) Hyperlipoproteinemia	University Medical Centre Ljubljana	N/A	D (30)